ERK/MAPK pathways play critical roles in EGFR ligands-induced MMP1 expression

Biochemical and Biophysical Research Communications

Volumn 407, Issue 4, 2011, Pages 680-686

  Park, Sarah ^a,b   Jung, Hae Hyun ^b   Park, Yeon Hee ^b   Ahn, Jin Seok ^b   Im, Young Hyuck ^b  

^a The Catholic University of Korea   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Breast cancer; EGF; Matrix metalloproteinase; TGF

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; CANERTINIB; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; INTERSTITIAL COLLAGENASE; LAPATINIB; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSLATION REGULATION; WESTERN BLOTTING;

BREAST NEOPLASMS; BUTADIENES; CELL LINE, TUMOR; CHROMONES; ENZYME ACTIVATION; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; LIGANDS; MATRIX METALLOPROTEINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MORPHOLINES; NEUREGULIN-1; NITRILES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 79955047298     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.03.075     Document Type: Article

References (26)

1. Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 2006, 69:562-573.
2. Page-McCaw A., Ewald A.J., Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 2007, 8:221-233.
3. Vizoso F.J., Gonzalez L.O., Corte M.D., Rodriguez J.C., Vazquez J., Lamelas M.L., Junquera S., Merino A.M., Garcia-Muniz J.L. Study of matrix metalloproteinases and their inhibitors in breast cancer. Br. J. Cancer 2007, 96:903-911.
4. Ueno H., Nakamura H., Inoue M., Imai K., Noguchi M., Sato H., Seiki M., Okada Y. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res. 1997, 57:2055-2060.
5. Tokuraku M., Sato H., Murakami S., Okada Y., Watanabe Y., Seiki M. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int. J. Cancer 1995, 64:355-359.
6. Nomura H., Sato H., Seiki M., Mai M., Okada Y. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res. 1995, 55:3263-3266.
7. Gupta G.P., Nguyen D.X., Chiang A.C., Bos P.D., Kim J.Y., Nadal C., Gomis R.R., Manova-Todorova K., Massague J. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 2007, 446:765-770.
8. Murray G.I., Duncan M.E., O'Neil P., McKay J.A., Melvin W.T., Fothergill J.E. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J. Pathol. 1998, 185:256-261.
9. Uchibori M., Nishida Y., Nagasaka T., Yamada Y., Nakanishi K., Ishiguro N. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma. Int. J. Oncol. 2006, 28:33-42.
10. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
11. Overall C.M. Dilating the degradome: matrix metalloproteinase 2 (MMP-2) cuts to the heart of the matter. Biochem. J. 2004, 383:e5-e7.
12. McCawley L.J., Matrisian L.M. Matrix metalloproteinases: they're not just for matrix anymore!. Curr. Opin. Cell Biol. 2001, 13:534-540.
13. Lo H.W., Hsu S.C., Hung M.C. EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res. Treat. 2006, 95:211-218.
14. Wells A. Tumor invasion: role of growth factor-induced cell motility. Adv. Cancer Res. 2000, 78:31-101.
15. Andl C.D., Mizushima T., Oyama K., Bowser M., Nakagawa H., Rustgi A.K. EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287:G1227-G1237.
16. Garbett E.A., Reed M.W., Stephenson T.J., Brown N.J. Proteolysis in human breast cancer. Mol. Pathol. 2000, 53:99-106.
17. Ono M., Kuwano M. Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs. Clin. Cancer Res. 2006, 12:7242-7251.
18. Nieto Y., Nawaz F., Jones R.B., Shpall E.J., Nawaz S. Prognostic significance of overexpression and phosphorylation of epidermal growth factor receptor (EGFR) and the presence of truncated EGFRvIII in locoregionally advanced breast cancer. J. Clin. Oncol. 2007, 25:4405-4413.
19. Lu X., Wang Q., Hu G., Van Poznak C., Fleisher M., Reiss M., Massague J., Kang Y. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev. 2009, 23:1882-1894.
20. Park Y.H., Jung H.H., Ahn J.S., Im Y.H. Ets-1 upregulates HER2-induced MMP-1 expression in breast cancer cells. Biochem. Biophys. Res. Commun. 2008, 377:389-394.
21. Chambers A.F., Groom A.C., MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2002, 2:563-572.
22. Tsai M.S., Shamon-Taylor L.A., Mehmi I., Tang C.K., Lupu R. Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer. Oncogene 2003, 22:761-768.
23. Rojas A., Romeu A. 3'-Flanking region of a family 1 beta-glucosidase gene. Biochem. J. 1996, 320(Pt. 2):693-694.
24. Kumagai K., Ohno I., Okada S., Ohkawara Y., Suzuki K., Shinya T., Nagase H., Iwata K., Shirato K. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J. Immunol. 1999, 162:4212-4219.
25. Brinckerhoff C.E., Matrisian L.M. Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell Biol. 2002, 3:207-214.
26. Page-McCaw A. Remodeling the model organism: matrix metalloproteinase functions in invertebrates. Semin. Cell Dev. Biol. 2008, 19:14-23.